FENC · Fennec Pharmaceuticals Inc
United States · RS rating 68 · As of 2026-10-14
| Price | 9.98 USD |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 33 / 45 / 72 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 41 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +105.9% |
| Sales growth Q/Q | +10.6% |
| Distance from 52-week high | +21.9% |
| Market cap (USD) | $229.6M |